![]() JAK3/BTK-IN-3 structure
|
Common Name | JAK3/BTK-IN-3 | ||
---|---|---|---|---|
CAS Number | 2674036-98-5 | Molecular Weight | 420.51 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C22H28N8O | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of JAK3/BTK-IN-3JAK3/BTK-IN-3 is a potent inhibitor of JAK3/BTK. BTK and JAK3 are two important targets for autoimmune diseases. Simultaneous inhibition of the BTK/JAK3 signalling pathway exhibits synergistic effects. JAK3/BTK-IN-3 has the potential for the research of JAK3 kinase and/or BTK-related diseases (extracted from patent WO2021147952A1, compound 009)[1] |
Name | JAK3/BTK-IN-3 |
---|
Description | JAK3/BTK-IN-3 is a potent inhibitor of JAK3/BTK. BTK and JAK3 are two important targets for autoimmune diseases. Simultaneous inhibition of the BTK/JAK3 signalling pathway exhibits synergistic effects. JAK3/BTK-IN-3 has the potential for the research of JAK3 kinase and/or BTK-related diseases (extracted from patent WO2021147952A1, compound 009)[1] |
---|---|
Related Catalog | |
References |
[1]. Guobao Zhang, et al. Pyrimidopyrroles. Patent WO2021147952A1. |
Molecular Formula | C22H28N8O |
---|---|
Molecular Weight | 420.51 |